<DOC>
	<DOCNO>NCT02729727</DOCNO>
	<brief_summary>To evaluate safety treatment effect CryoBalloon™ Full Ablation System ablation human esophageal epithelium patient schedule undergo esophagectomy</brief_summary>
	<brief_title>Clinical Study Evaluate CryoBalloon™ Ablation System Patients Undergoing Esophagectomy</brief_title>
	<detailed_description>The primary outcome study safety treatment effect CryoBalloon™ Ablation System . An esophagectomy perform schedule follow ablation procedure ; histopathological analysis surgically-resected specimen perform determine treatment effect .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>Up two ( 2 ) area 3 cm nonulcerated , columnar line esophagus squamous linted tissue suitable ablation Older 18 year age time consent Requires clinicallynecessary esophagectomy esophageal cancer Patient provide write informed consent use Informed Consent Form approve Institution 's review Medical Ethics Committee ( MEC ) Patient refuse unable provide write informed consent Patient esophageal narrow limit access intend site ablation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>